|
Phocoena
|
B01.050.150.900.649.313.875.566.600 |
|
|
Porpoises
|
B01.050.150.900.649.313.875.566 |
|
|
Porifera
|
D011161 |
[The phylum of sponges which are sessile, suspension-feeding, multicellular animals that utilize flagellated cells called choanocytes to circulate water. Most are hermaphroditic. They are probably an early evolutionary side branch that gave rise to no other group of animals. Except for about 150 freshwater species, sponges are marine animals. They are a source of ALKALOIDS; STEROLS; and other complex molecules useful in medicine and biological research.
, The largest class in the phylum PORIFERA, comprised of over 95% of all living species. Most have siliceous spicules and/or a fibrous skeleton.
] |
|
Angelman Syndrome
|
C16.131.260.040 |
|
|
Porphobilinogen
|
D011162 |
|
|
Hydroxymethylbilane Synthase
|
D011163 |
[An enzyme that catalyzes the tetrapolymerization of the monopyrrole PORPHOBILINOGEN into the hydroxymethylbilane preuroporphyrinogen (UROPORPHYRINOGENS) in several discrete steps. It is the third enzyme in the 8-enzyme biosynthetic pathway of HEME. In humans, deficiency in this enzyme encoded by HMBS (or PBGD) gene results in a form of neurological porphyria (PORPHYRIA, ACUTE INTERMITTENT). This enzyme was formerly listed as EC 4.3.1.8
] |
|
Porphyrias
|
D011164 |
[A diverse group of metabolic diseases characterized by errors in the biosynthetic pathway of HEME in the LIVER, the BONE MARROW, or both. They are classified by the deficiency of specific enzymes, the tissue site of enzyme defect, or the clinical features that include neurological (acute) or cutaneous (skin lesions). Porphyrias can be hereditary or acquired as a result of toxicity to the hepatic or erythropoietic marrow tissues.
] |
|
Nephroblastoma Overexpressed Protein
|
D12.644.276.200.500 |
|
|
CCN Intercellular Signaling Proteins
|
D12.644.276.200 |
|
|
Siphoviridae
|
B04.280.090.800 |
|
|
Porphyrinogens
|
D011165 |
[Colorless reduced precursors of porphyrins in which the pyrrole rings are linked by methylene (-CH2-) bridges.
] |
|
Porphyrins
|
D011166 |
[A group of compounds containing the porphin structure, four pyrrole rings connected by methine bridges in a cyclic configuration to which a variety of side chains are attached. The nature of the side chain is indicated by a prefix, as uroporphyrin, hematoporphyrin, etc. The porphyrins, in combination with iron, form the heme component in biologically significant compounds such as hemoglobin and myoglobin.
] |
|
Granulosa Cell Tumor
|
C13.351.500.056.630.705.398 |
|
|
External Fixators
|
E07.858.442.660.430 |
|
|
Portacaval Shunt, Surgical
|
D011167 |
[Surgical portasystemic shunt between the portal vein and inferior vena cava.
] |
|
Portal System
|
D011168 |
[A system of vessels in which blood, after passing through one CAPILLARY BED, is conveyed through a second set of capillaries before it returns to the systemic circulation. It pertains especially to the hepatic portal system.
] |
|
E2F5 Transcription Factor
|
D050700 |
[An E2F transcription factor that represses GENETIC TRANSCRIPTION required for CELL CYCLE entry and DNA synthesis. E2F5 recruits chromatin remodeling factors indirectly to target gene promoters through RETINOBLASTOMA LIKE PROTEIN P130.
] |
|
Blood Coagulation
|
D001777 |
[The process of the interaction of BLOOD COAGULATION FACTORS that results in an insoluble FIBRIN clot.
] |
|
History, Modern 1601-
|
D049711 |
[The period of the history of medicine from 1601 A.D. to the present.
, The period of history from 1601 of the common era to the present.
] |
|
E2F6 Transcription Factor
|
D050701 |
[An E2F transcription factor that represses GENETIC TRANSCRIPTION required for CELL CYCLE entry and DNA synthesis. E2F6 recruits chromatin remodeling factors directly to target gene promoters and lacks the transactivation domain responsible for binding to the retinoblastoma family of tumor suppressors.
] |
